首页> 外文期刊>Journal of Pathology Informatics >Bridging the collaboration gap: Real-time identification of clinical specimens for biomedical research
【24h】

Bridging the collaboration gap: Real-time identification of clinical specimens for biomedical research

机译:弥合协作差距:生物医学研究临床标本的实时鉴定

获取原文
           

摘要

Introduction: Biomedical and translational research often relies on the evaluation of patients or specimens that meet specific clinical or laboratory criteria. The typical approach used to identify biospecimens is a manual, retrospective process that exists outside the clinical workflow. This often makes biospecimen collection cost prohibitive and prevents the collection of analytes with short stability times. Emerging data architectures offer novel approaches to enhance specimen-identification practices. To this end, we present a new tool that can be deployed in a real-time environment to automate the identification and notification of available biospecimens for biomedical research. Methods: Real-time clinical and laboratory data from Cloverleaf (Infor, NY, NY) were acquired within our computational health platform, which is built on open-source applications. Study-specific filters were developed in NiFi (Apache Software Foundation, Wakefield, MA, USA) to identify the study-appropriate specimens in real time. Specimen metadata were stored in Elasticsearch (Elastic N. V., Mountain View, CA, USA) for visualization and automated alerting. Results: Between June 2018 and December 2018, we identified 2992 unique specimens belonging to 2815 unique patients, split between two different use cases. Based on laboratory policy for specimen retention and study-specific stability requirements, secure E-mail notifications were sent to investigators to automatically notify of availability. The assessment of throughput on commodity hardware demonstrates the ability to scale to approximately 2000 results per second. Conclusion: This work demonstrates that real-world clinical data can be analyzed in real time to increase the efficiency of biospecimen identification with minimal overhead for the clinical laboratory. Future work will integrate additional data types, including the analysis of unstructured data, to enable more complex cases and biospecimen identification.
机译:介绍:生物医学和翻译研究往往依赖于符合特定临床或实验室标准的患者或标本的评估。用于识别BioPexecens的典型方法是在临床工作流程之外存在的手动,回顾性过程。这通常使BioPecimen收集成本令人抑制并阻止具有短稳定时间的分析物的集合。新兴数据架构提供了提高样本识别实践的新方法。为此,我们提出了一个新工具,可以在实时环境中部署,以自动化可用生物医学研究的可用生物开发的识别和通知。方法:在我们的计算健康平台中获得了Cloverleaf(Infor,NY,NY)的实时临床和实验室数据,建立在开源应用中。学习特定的过滤器是在NiFi(Apache Software Foundation,Wakefield,Ma,USA)中开发的,以实时识别研究适当的标本。标本元数据储存在Elasticsearch(Elastic N. V.,山景,CA,USA)中,用于可视化和自动化警报。结果:2018年6月至2018年12月,我们确定了2992名属于2815名独特患者的标本,分为两种不同的用例。根据实验室保留和学习特定稳定要求的实验室政策,将安全电子邮件通知发送给调查人员,以自动通知可用性。商品硬件吞吐量评估表明,每秒扩展到大约2000个结果的能力。结论:这项工作表明,现实世界的临床数据可以实时分析,以提高生物自化识别效率,临床实验室的最小开销。将来的工作将集成其他数据类型,包括对非结构化数据的分析,以实现更复杂的案例和生物自播识别。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号